Literature DB >> 17586833

Cumulative pregnancy rates after a maximum of nine cycles of modified natural cycle IVF and analysis of patient drop-out: a cohort study.

M J Pelinck1, N E A Vogel, E G J M Arts, A H M Simons, M J Heineman, A Hoek.   

Abstract

BACKGROUND: In modified natural cycle IVF (MNV-IVF), treatment is aimed at using the one follicle that spontaneously develops to dominance, using a GnRH antagonist together with gonadotrophins in the late follicular phase only.
METHODS: In this single-centre cohort study, nine cycles of MNV-IVF were offered to 268 patients. Cumulative pregnancy rates (CPRs) were calculated and drop-out was analysed. The present study is an extension of earlier studies in which three cycles of MNV-IVF were offered to the same patients.
RESULTS: A total of 256 patients completed 1048 cycles (4.1 per patient). Embryo transfer rate was 36.5% per started cycle. Ongoing pregnancy rate was 7.9% per started cycle and 20.7% per embryo transfer. Including treatment-independent pregnancies, the observed CPR after up to nine cycles was 44.4% (95% confidence interval 38.3-50.5) per patient. Pregnancy rates per started cycle did not decline in higher cycle numbers (overall 9.9%). Drop-out rates were high (overall 47.8%). We found that cancellation of oocyte retrieval, fertilization failure and failure to reach embryo transfer are repeating phenomena in subsequent cycles and furthermore that these events predispose for drop-out.
CONCLUSIONS: CPR after nine cycles of MNV-IVF in this study was 44.4%. Pregnancy rate per cycle did not decline in higher cycle numbers, possibly due to selective drop-out of poor prognosis patients. Due to the low-risk and patient-friendly nature of the MNC protocol, it seems a feasible treatment option for patients requiring IVF.

Entities:  

Mesh:

Year:  2007        PMID: 17586833     DOI: 10.1093/humrep/dem164

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study.

Authors:  Ermanno Greco; Katarzyna Litwicka; Cristiana Arrivi; Maria Teresa Varricchio; Daniela Zavaglia; Cecilia Mencacci; Maria Giulia Minasi
Journal:  J Assist Reprod Genet       Date:  2013-11       Impact factor: 3.412

2.  Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience.

Authors:  Talya Shaulov; Maria P Vélez; Karen Buzaglo; Simon J Phillips; Isaac Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2015-06-04       Impact factor: 3.412

3.  Couples' discontinuation of fertility treatments: a longitudinal study on demographic, biomedical, and psychosocial risk factors.

Authors:  Juliana Pedro; Maria Pedro Sobral; Joana Mesquita-Guimarães; Carla Leal; Maria E Costa; Mariana V Martins
Journal:  J Assist Reprod Genet       Date:  2016-11-29       Impact factor: 3.412

Review 4.  Ultrastructural Evaluation of the Human Oocyte at the Germinal Vesicle Stage during the Application of Assisted Reproductive Technologies.

Authors:  Maria Grazia Palmerini; Sevastiani Antonouli; Guido Macchiarelli; Sandra Cecconi; Serena Bianchi; Mohammad Ali Khalili; Stefania Annarita Nottola
Journal:  Cells       Date:  2022-05-13       Impact factor: 7.666

5.  Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation.

Authors:  A J Bensdorp; R I Tjon-Kon-Fat; P M M Bossuyt; C A M Koks; G J E Oosterhuis; A Hoek; P G A Hompes; F J M Broekmans; H R Verhoeve; J P de Bruin; R van Golde; S Repping; B J Cohlen; M D A Lambers; P F van Bommel; E Slappendel; D Perquin; J M Smeenk; M J Pelinck; J Gianotten; D A Hoozemans; J W M Maas; M J C Eijkemans; F van der Veen; B W J Mol; M van Wely
Journal:  BMJ       Date:  2015-01-09

Review 6.  Direct-to-consumer advertising of success rates for medically assisted reproduction: a review of national clinic websites.

Authors:  Jack Wilkinson; Andy Vail; Stephen A Roberts
Journal:  BMJ Open       Date:  2017-01-12       Impact factor: 2.692

7.  Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.

Authors:  Qiuju Chen; Yun Wang; Lihua Sun; Shaozhen Zhang; Weiran Chai; Qingqing Hong; Hui Long; Li Wang; Qifeng Lyu; Yanping Kuang
Journal:  Reprod Biol Endocrinol       Date:  2017-09-05       Impact factor: 5.211

8.  Decrease in preovulatory serum estradiol is a valuable marker for predicting premature ovulation in natural/unstimulated in vitro fertilization cycle.

Authors:  Xuefeng Lu; Shuzin Khor; Qianqian Zhu; Lihua Sun; Yun Wang; Qiuju Chen; Ling Wu; Yonglun Fu; Hui Tian; Qifeng Lyu; Renfei Cai; Yanping Kuang
Journal:  J Ovarian Res       Date:  2018-11-21       Impact factor: 4.234

9.  Accumulation of embryos over 3 natural modified IVF (ICSI) cycles followed by transfer to improve the outcome of poor responders.

Authors:  A K Datta; S Campbell; N Felix; G Nargund
Journal:  Facts Views Vis Obgyn       Date:  2019-03

Review 10.  Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment.

Authors:  S Gameiro; J Boivin; L Peronace; C M Verhaak
Journal:  Hum Reprod Update       Date:  2012-08-06       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.